![]() In Germany, the country where this study was conducted, diabetes prevalence is currently at 9.0%, and more than 95.0% of those are suffering from type 2 diabetes. In 2014, 4.9 million people died from diabetes-related complications. The amount of undiagnosed cases is estimated to be between 27.1% and 53.6%. The prevalence of diabetes varies between the continents, with 5.1% in Africa and 11.4% in North America and the Caribbean. This number is expected to rise to 205 million people by the year 2035. Hence, they offer great potential to support therapy management, increase therapy adherence, and reduce the probability of accompanying and secondary disease occurrence.Ĭurrently, 387 million people aged 20 to 79 years suffer from diabetes worldwide. In addition to the documentation of blood glucose values, such apps are able to graphically depict those values, offer an analysis of trends, provide additional information about the disease, or to share relevant data with the attending physician. Numerous mobile apps exist that aim to support the self-management of patients with type 1 and type 2 diabetes. Personal contact persons, especially during the initial phase of use, are of utmost importance to reduce the fear of data loss or erroneous data input, and to raise acceptance among this target group. Therefore, a helpful diabetes app should be individually adaptable. Furthermore, it has been shown that the needs of the investigated target group are highly heterogeneous due to varying previous knowledge, age, type of diabetes, and therapy. The most important contact persons for technical questions were family members (19/31, 61%).Ĭonclusions: A lack of additional benefits and ease of use emerged as the key factors for the acceptance of diabetes apps among patients aged 50 or older. The most important contents of a helpful diabetes app were reported as the ability to add remarks to measured values (9/28, 32%), the definition of thresholds for blood glucose values and highlighting deviating values (7/28, 25%), and a reminder feature for measurement/medication (7/28, 25%). Furthermore, the patients felt the apps lacked individually important functions (11/29, 38%), or felt the functions that were offered were unnecessary for their own therapy needs (10/29, 34%). The app test revealed the following main difficulties in use: nonintuitive understanding of the functionality of the apps (26/29, 90%), nonintuitive understanding of the menu navigation/labeling (19/29, 66%), font sizes and representations that were too small (14/29, 48%), and difficulties in recognizing and pressing touch-sensitive areas (14/29, 48%). The reasons reported for being against the use of apps were a lack of additional benefits (4/8, 50%) compared to current therapy management, a lack of interoperability with other devices/apps (1/8, 12%), and no joy of use (1/8, 12%). Of 32 participants, 15 (47%) knew apps, however only 2 (6%) had already used a diabetes app within their therapy. Results: Altogether, 32 patients with diabetes were interviewed. At the end of each interview, the patients tested two existing diabetes apps to reveal obstacles in (first) use. Methods: Guided interviews were chosen in order to get a comprehensive insight into the subjective perspective of elderly diabetes patients. This qualitative study was the third of three substudies investigating factors influencing acceptance of diabetes apps among patients aged 50 or older. Objective: We investigated the question “Which factors influence the acceptance of diabetes apps among patients aged 50 or older?” Particular emphasis was placed on the current use of mobile devices/apps, acceptance-promoting/-inhibiting factors, features of a helpful diabetes app, and contact persons for technical questions. However, they are rarely used by elderly patients due to a lack of acceptance. Research Association Public Health Saxony and Saxony-AnhaltĮmail: Mobile apps for people with diabetes offer great potential to support therapy management, increase therapy adherence, and reduce the probability of the occurrence of accompanying and secondary diseases. Asian/Pacific Island Nursing Journal 10 articles.JMIR Bioinformatics and Biotechnology 32 articles.JMIR Biomedical Engineering 68 articles.Journal of Participatory Medicine 78 articles.JMIR Perioperative Medicine 89 articles.JMIR Rehabilitation and Assistive Technologies 201 articles.JMIR Pediatrics and Parenting 279 articles.Interactive Journal of Medical Research 306 articles.JMIR Public Health and Surveillance 1141 articles.Journal of Medical Internet Research 7471 articles. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |